Horizon 2020

First patient has been implanted with a novel drug delivery system, developed by Renishaw, for a new clinical study investigating it as a delivery method for cerebral dopamine neurotrophic factor (CDNF) as a treatment for Parkinson’s disease. more


Scottish biotechnology company, TC BioPharm (TCB), has been selected to receive a €4 million grant from the European Union’s (EU’s) research and innovation programme, Horizon 2020. more


Scientific technology company Renishaw is being supported by the Horizon 2020 programme for its trials of a new drug delivery system aiming to help treat Parkinson’s disease. more


A £4m trial will establish whether routinely treating stoke patients with paracetamol and antibiotics could save up to 25,000 lives each year. more